Home > Journals > Chinese Pharmacological Bulletin >Issue 02,2019
Chinese Pharmacological Bulletin
Translated from the Chinese edition
Supervised by CHINA ASSOCIATION FOR SCIENCE AND TECHNOLOGY
Sponsored by chinese phrmacological socity
ISSN 1001-1978 CN 34-1086/R

12 issues per year
Discipline(s): Medical Science

Current Issue: Issue 02, 2019  

Total Downloads:151

  • Chinese Pharmacological Bulletin is supervised by China Association for Science and Technology and sponsored by Chinese Pharmacological Society. The journal mainly publishes the original research reports and reviews on pharmacology. The readers of Chinese Pharmacological Bulletin mainly include research workers in pharmacological, medical and other related areas, clinical physicians, pharmacists and pharmaceutical industry technical personnel at different levels. The columns cover chiefly on original articles, reviews and lectures, experimental methodologies, research bulletins and short monographs. The journal is included in CA, JST and CSCD.

  • Editor-in-Chief
    Wei Wei
    Li Jun

    Deputy Editor-in-Chief
    Lin Zhibin
    Du Guanghua
    Huang Hesheng

<<Previous Issue Issue 02,2019 Next Issue>>

Sodium selenite induced human lung cancer A549 cells apoptosis through Keap1/Nrf2/ARE signaling pathway

TIAN Chong-mei;XIA Dao-zong;XING Meng-yu;GUO Lu;ZHANG Xiao-xi;ZHAO Xin-yu

Vol 35,No. 02

miR-27a-3p inhibited synthesis of Col Ⅰ and Col Ⅲ in pulmonary fibroblasts through Wnt3a/β-catenin signaling pathway

LIU Li-jing;QIAN Hong;HU Ke;ZHANG Zi-zhen;HE Jian-bin

Vol 35,No. 02

Inhibitory functions of SAaB on LPS-induced RAW264.7 cells via NF-κB-iNOS-NO signaling pathway

ZHONG Yan-mei;CHEN Jian-ping;CHEN Shu-ling;FENG Yi-fan;ZHONG Xun-long

Vol 35,No. 02